BE905502A - 2-oxo-1- (((sulfonyle substitue) amino) carbonyl) azetidines, leur preparation et leur utilisation. - Google Patents

2-oxo-1- (((sulfonyle substitue) amino) carbonyl) azetidines, leur preparation et leur utilisation.

Info

Publication number
BE905502A
BE905502A BE0/217217A BE217217A BE905502A BE 905502 A BE905502 A BE 905502A BE 0/217217 A BE0/217217 A BE 0/217217A BE 217217 A BE217217 A BE 217217A BE 905502 A BE905502 A BE 905502A
Authority
BE
Belgium
Prior art keywords
preparation
azetidines
oxo
carbonyl
amino
Prior art date
Application number
BE0/217217A
Other languages
English (en)
French (fr)
Original Assignee
Squibb & Sons Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Squibb & Sons Inc filed Critical Squibb & Sons Inc
Publication of BE905502A publication Critical patent/BE905502A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
BE0/217217A 1985-09-26 1986-09-26 2-oxo-1- (((sulfonyle substitue) amino) carbonyl) azetidines, leur preparation et leur utilisation. BE905502A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US78047985A 1985-09-26 1985-09-26

Publications (1)

Publication Number Publication Date
BE905502A true BE905502A (fr) 1987-01-16

Family

ID=25119699

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/217217A BE905502A (fr) 1985-09-26 1986-09-26 2-oxo-1- (((sulfonyle substitue) amino) carbonyl) azetidines, leur preparation et leur utilisation.

Country Status (31)

Country Link
JP (1) JPS6284082A (cg-RX-API-DMAC7.html)
KR (1) KR900001013B1 (cg-RX-API-DMAC7.html)
CN (1) CN86106980A (cg-RX-API-DMAC7.html)
AT (1) ATA257986A (cg-RX-API-DMAC7.html)
AU (1) AU600912B2 (cg-RX-API-DMAC7.html)
BE (1) BE905502A (cg-RX-API-DMAC7.html)
CA (1) CA1308719C (cg-RX-API-DMAC7.html)
CH (1) CH670828A5 (cg-RX-API-DMAC7.html)
DD (1) DD250121A5 (cg-RX-API-DMAC7.html)
DE (1) DE3632876A1 (cg-RX-API-DMAC7.html)
DK (1) DK460386A (cg-RX-API-DMAC7.html)
EG (1) EG18314A (cg-RX-API-DMAC7.html)
ES (1) ES2001995A6 (cg-RX-API-DMAC7.html)
FI (1) FI863890A7 (cg-RX-API-DMAC7.html)
FR (1) FR2587700B1 (cg-RX-API-DMAC7.html)
GB (1) GB2181130B (cg-RX-API-DMAC7.html)
GR (1) GR862449B (cg-RX-API-DMAC7.html)
HU (1) HU198044B (cg-RX-API-DMAC7.html)
IE (1) IE59686B1 (cg-RX-API-DMAC7.html)
IL (1) IL80160A (cg-RX-API-DMAC7.html)
IT (1) IT1214533B (cg-RX-API-DMAC7.html)
LU (1) LU86611A1 (cg-RX-API-DMAC7.html)
NL (1) NL8602446A (cg-RX-API-DMAC7.html)
NO (1) NO863837L (cg-RX-API-DMAC7.html)
NZ (1) NZ217704A (cg-RX-API-DMAC7.html)
PH (1) PH23315A (cg-RX-API-DMAC7.html)
PL (1) PL151546B1 (cg-RX-API-DMAC7.html)
PT (1) PT83440B (cg-RX-API-DMAC7.html)
SE (1) SE8604089L (cg-RX-API-DMAC7.html)
YU (1) YU46177B (cg-RX-API-DMAC7.html)
ZA (1) ZA867373B (cg-RX-API-DMAC7.html)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4975538A (en) * 1987-03-03 1990-12-04 The Upjohn Company Antibiotic sulfonylaminocarbonyl activated beta-lactams
US5001235A (en) * 1987-02-27 1991-03-19 The Upjohn Company Antibiotic beta-lactams containing a pyridone carboxylic acid or acid derivative
US5006650A (en) * 1987-02-11 1991-04-09 The Upjohn Company Novel N-1 substituted beta-lactams as antibiotics
US5015737A (en) * 1987-07-22 1991-05-14 The Upjohn Company Therapeutically useful beta-lactams

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01502660A (ja) * 1986-05-23 1989-09-14 ジ・アップジョン・カンパニー N―1置換スルホニルアミノカルボニル、c―4置換モノバクタム類
DE3864257D1 (de) * 1987-02-11 1991-09-19 Upjohn Co Neue n-1 substituierte beta-lactame als antibiotika.
US4772693A (en) * 1987-07-01 1988-09-20 E. R. Squibb & Sons, Inc. 2-oxo-1-((Substituted sulfonyl)amino)-carbonyl)azetidines
US4762922A (en) * 1987-07-01 1988-08-09 Squibb Corporation 2-oxo-1-[[(substituted sulfonyl)amino]-carbonyl]azetidines
WO1989000569A1 (en) * 1987-07-22 1989-01-26 The Upjohn Company THERAPEUTICALLY USEFUL beta-LACTAMS
US4777252A (en) * 1987-08-13 1988-10-11 E. R. Squibb & Sons, Inc. 2-oxo-1-[[(substituted sulfonyl)amino]-carbonyl]azetidines
US4889930A (en) * 1987-12-21 1989-12-26 E. R. Squibb & Sons, Inc. Process for making 2-oxo-1-((substituted sulfonyl)amino)carbonzyl)azetidines and intermediates used therein
US4871841A (en) * 1987-12-23 1989-10-03 E. R. Squibb & Sons, Inc. 2-Oxo-1-[[(substituted sulfonyl)amino]-carbonyl]azetidines
JPH01290674A (ja) * 1988-04-04 1989-11-22 E R Squibb & Sons Inc アゼチジニル誘導体
US4959470A (en) * 1988-08-17 1990-09-25 E. R. Squibb & Sons, Inc. 2-oxo-[[(substituted sulfonyl)-amino]carbonyl]-azetidines
EP0604365B1 (en) * 1992-12-23 1999-05-26 Novartis AG Imidazole derivatives and their use as agrochemical agents
DE69405535T2 (de) * 1994-03-11 1998-04-02 Agfa Gevaert Nv Photographisches Material, das einen neuen Typ eines Hydrazides enthält
KR100596360B1 (ko) * 2003-07-15 2006-07-03 한국생명공학연구원 항암 활성을 갖는 신규 2-옥소-피페리딘 유도체(ⅰ)화합물을 포함하는 암 질환 치료를 위한 약학 조성물
WO2005063704A1 (ja) * 2003-12-25 2005-07-14 Ono Pharmaceutical Co., Ltd. アゼチジン環化合物およびその医薬
GB201111704D0 (en) 2011-07-07 2011-08-24 Takeda Pharmaceutical Novel compounds
GB201111705D0 (en) 2011-07-07 2011-08-24 Takeda Pharmaceutical Compounds and their use
JO3115B1 (ar) 2011-08-22 2017-09-20 Takeda Pharmaceuticals Co مركبات بيريدازينون واستخدامها كمثبطات daao
AP2014007637A0 (en) 2011-11-15 2014-05-31 Takeda Pharmaceutical Dihydroxy aromatic heterocyclic compound
GB201222711D0 (en) 2012-12-17 2013-01-30 Takeda Pharmaceutical Novel compounds
CN106986820B (zh) * 2017-02-24 2019-05-21 浙江工商大学 多功能的羟基吡啶酮衍生物及其水合物的制备法和用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ199981A (en) * 1981-04-09 1985-08-16 Squibb & Sons Inc 2-oxo-1-(((substituted sulphonyl)amino)carbonyl)azetidines
CA1272726C (en) * 1982-01-04 1990-08-14 2-oxo-1-(aminocarbonylaminosulfonyl- aminocarbonyl)azetidines
US4939253A (en) * 1982-08-04 1990-07-03 E. R. Squibb & Sons, Inc. 2-oxoazetidin-1-yloxy acetic acids and analogs
US4801705A (en) * 1986-06-23 1989-01-31 E. R. Squibb & Sons, Inc. 2-oxo-1-(((substituted sulfonyl)amino)-carbonyl)azetidines

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5006650A (en) * 1987-02-11 1991-04-09 The Upjohn Company Novel N-1 substituted beta-lactams as antibiotics
US5001235A (en) * 1987-02-27 1991-03-19 The Upjohn Company Antibiotic beta-lactams containing a pyridone carboxylic acid or acid derivative
US4975538A (en) * 1987-03-03 1990-12-04 The Upjohn Company Antibiotic sulfonylaminocarbonyl activated beta-lactams
US5015737A (en) * 1987-07-22 1991-05-14 The Upjohn Company Therapeutically useful beta-lactams

Also Published As

Publication number Publication date
YU165986A (en) 1988-06-30
FI863890A0 (fi) 1986-09-26
PL261575A1 (en) 1988-07-21
NO863837D0 (no) 1986-09-26
FI863890A7 (fi) 1987-03-27
ZA867373B (en) 1987-05-27
PH23315A (en) 1989-07-14
HU198044B (en) 1989-07-28
FR2587700B1 (fr) 1988-09-16
GB2181130B (en) 1989-09-20
PT83440B (pt) 1989-05-12
CN86106980A (zh) 1987-04-08
AU600912B2 (en) 1990-08-30
IT1214533B (it) 1990-01-18
YU46177B (sh) 1993-05-28
FR2587700A1 (fr) 1987-03-27
NZ217704A (en) 1989-02-24
HUT44535A (en) 1988-03-28
ATA257986A (de) 1994-07-15
ES2001995A6 (es) 1988-07-01
NO863837L (no) 1987-03-27
PL151546B1 (en) 1990-09-28
JPS6284082A (ja) 1987-04-17
KR900001013B1 (ko) 1990-02-24
LU86611A1 (fr) 1987-04-02
IL80160A0 (en) 1986-12-31
CA1308719C (en) 1992-10-13
GR862449B (en) 1987-01-27
DD250121A5 (de) 1987-09-30
SE8604089D0 (sv) 1986-09-26
GB8623151D0 (en) 1986-10-29
PT83440A (pt) 1986-10-01
DK460386A (da) 1987-03-27
EG18314A (en) 1993-02-28
KR870003101A (ko) 1987-04-15
DE3632876A1 (de) 1987-04-02
CH670828A5 (cg-RX-API-DMAC7.html) 1989-07-14
NL8602446A (nl) 1987-04-16
GB2181130A (en) 1987-04-15
IL80160A (en) 1991-04-15
IT8621834A0 (it) 1986-09-26
IE862547L (en) 1987-03-26
DK460386D0 (da) 1986-09-26
AU6315686A (en) 1987-04-02
IE59686B1 (en) 1994-03-23
SE8604089L (sv) 1987-03-27

Similar Documents

Publication Publication Date Title
IT8621358A0 (it) Composizione farmaceutica adattivita' analgesica.
FI863362A7 (fi) Farmaseuttinen koostumus.
EP0296622A3 (en) Derivatives of poly(diallyl-methylamine) and their use as cholesterol-lowering agents
AU8188987A (en) Improved metal complex-containing pharmaceutical agents
FR2651294B1 (fr) Unite d'etancheite.
DE3853600D1 (de) Selektiv und partiell hydrogeniertes Polymer und Kautschukmischung welche dieses Polymer enthält.
AU2091988A (en) 2-oxo-1-(((substituted sulfonyl)amino)carbonyl)-azetidines
MY101784A (en) Novel pharmacological compounds
AU6315686A (en) 2-oxo-1-(((substituted sulfonyl)amino)carbonyl)-azetidines
FR2603202B1 (fr) Jouet en forme d'arche de noe.
DE3852988D1 (de) Propylen-Ethylen-Blockcopolymer Zusammensetzung.
AU6816687A (en) (2,2-bis(aminomethyl)-1,3-propanediol-n,n') platinum complexes
FI872313A0 (fi) Farmaceutiska kompositioner.
DE3764192D1 (de) Schmiermittel und polyfluorierte verbindungen, verwendbar als zusaetze.
DE3767178D1 (de) Heisshaertbare stoffgemische enthaltend substituierte bicyclo (2.2.1)hept-5-en-2,3-dicarbonsaeureimide und polymaleinimide.
DE3781337D1 (de) 2-oxo-1-(((substituiertes sulfonyl)amino)-carbonyl)-azetidine.
FI872216L (fi) Avlaegsnande av krom ur cellvaetska.
IT8621397A0 (it) Derivati del pirrolidin-2-one adattivita' nootropa.
IT8520234A0 (it) Composizione farmaceutiche adattivita' dopominergica.
DE3750305D1 (de) Polymaleimid und eine Zusammensetzung, die dieses Polymer enthält.
IT8821173A0 (it) 2 osso 1[[(solfonil)ammino]carbonil]azetidine sostituite in solfonile adattivita' antibatterica.
EP0226842A3 (en) Substituted 1,4-naphthalenediones, processes for their preparation and pharmaceutical compositions containing them
NL194166B (nl) Naftoxazinen en bereiding en toepassing daarvan. Hexahydronaft[2,3-b]-1,4-oxazinen en farmaceutische preparaten die ze bevatten.
IT8821174A0 (it) 2 osso 1[[(solfonil sostituite)ammino] carbonil] azetidine ad attivita' antibatterica.
DE69019087D1 (de) Gemischtes isdn vermittlungssystem.

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: E.R. SQUIBB & SONS, INC.

Effective date: 20000930